Contract HHSO100201600026C
Medicines Company, The · Department Of Health And Human Services · September 29, 2022
Medicines Company, The was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 29, 2022 for $6.14 million of work in research and development in biotechnology. Performance is in Parsippany, NJ. It was awarded under full and open competition. The contract has been modified 2 times since the base award It uses cost sharing contract pricing. The most recent modification was on February 20, 2026. If all options are exercised, the contract could reach $98.14 million.
Contract details
- PIID
- HHSO100201600026C
- Award type
- Definitive Contract
- Pricing
- Cost Sharing
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541711 · Research And Development In Biotechnology
- Product / service
- Health R&D Services; Health Care Services; Experimental Development
- Place of performance
- Parsippany, NJ
- First action
- September 29, 2022
- Latest action
- February 20, 2026
Description
ADD THE DEFINITION OF "DISCONTINUED PROGRAM" TO SECTION 1.B; ADD LANGUAGE TO THE "ORAVANCE PROGRAM" DEFINITION THAT STATES THE REMOVAL OF FURTHER PROGRESSION OF S-743229 FROM THE PORTFOLIO ; AND UPDATE THE PERIODS OF PERFORMANCE I
Modification timeline
-
February 20, 2026Mod P00012 · Supplemental Agreement For Work Within Scope$98.14M
-
September 26, 2025Mod P00011 · Supplemental Agreement For Work Within ScopeUPDATES THE ADDRESS OF QPEX/THE MEDICINES COMPANY; UPDATE THE PI AND DEPUTY PI; UPDATE THE JOC MEMBERSHIP; UPDATE THE NON-VOTING MEMBERS, UPDATE ALTERNATE ADMINISTRATIVE/CONTRACT CONTACT; UPDATE THE R…$98.14M
-
September 29, 2022Mod P00007 · Exercise An OptionMODIFICATION 7 PERFORMS THE FOLLOWING ACTIONS: 1.) ACTIVATES OPTION 4 (CLIN 0005) FOR PROGRAM MANAGEMENT, NON-CLINICAL TOXICOLOGY, NON-CLINICAL, CLINICAL, REGULATORY AND CMC ACTIVITIES TO ADVANCE THE…$88.14M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| University Of Illinois | Department Of Health And Human Services | March 26, 2026 | $2.27M |
| Battelle Memorial Institute | Department Of Health And Human Services | March 25, 2026 | $9.65M |
| University Of Texas Medical Branch At Galveston | Department Of Health And Human Services | March 23, 2026 | $1.61M |
| Regeneron Pharmaceuticals Inc | Department Of Health And Human Services | March 19, 2026 | $8.60M |
| Battelle Memorial Institute | Department Of Health And Human Services | March 17, 2026 | $2.22M |
| Battelle Memorial Institute | Department Of Health And Human Services | March 17, 2026 | $2.23M |
Top contractors in NAICS 541711
Lifetime obligated dollars across all federal contracts in this NAICS code.
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HHSO100201600026C?
Contract HHSO100201600026C is a federal contract awarded to Medicines Company, The by Department Of Health And Human Services on September 29, 2022 for $6.14 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY. It has been modified 2 times since the base award.
Who won contract HHSO100201600026C?
Medicines Company, The won contract HHSO100201600026C from Department Of Health And Human Services.
How much is contract HHSO100201600026C worth?
Contract HHSO100201600026C has obligated $6.14 million to date, with a total potential value of $98.14 million if all options are exercised.